
Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,782 products)
- Apoptosis(6,263 products)
- Cell Cycle/Checkpoint(4,792 products)
- Chromatin/Epigenetics(2,441 products)
- Cytoskeletal Signaling(1,528 products)
- DNA Damage/DNA Repair(2,965 products)
- Endocrinology/Hormones(3,707 products)
- Enzyme(3,667 products)
- GPCR/G-Protein(9,009 products)
- Immunology and Inflammation(3,875 products)
- Influenza Virus(301 products)
- JAK/STAT signaling(414 products)
- MAPK Signaling(1,248 products)
- Membrane Transporter/Ion Channel(3,033 products)
- Metabolism(10,209 products)
- Microbiology/Virology(7,592 products)
- Neuroscience(10,381 products)
- Other Inhibitors(36,040 products)
- Oxidation-Reduction(42 products)
- PI3K/Akt/mTOR Signaling(1,442 products)
- Proteases/Proteasome(1,724 products)
- Stem Cell and Derivatives(826 products)
- Tyrosine Kinase/Adaptors(2,035 products)
- Ubiquitination(1,717 products)
Show 16 more subcategories
Found 66683 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
TBK1/IKKε-IN-1
CAS:TBK1/IKKε-IN-1 is a dual inhibitor of TBK1 and IKKε (IC50s of <100 nM).Formula:C28H26N4O5Purity:98%Color and Shape:SolidMolecular weight:498.53NBTIs-IN-4
NBTIs-IN-4, a broad-spectrum Gram-positive antibacterial, inhibits DNA rotamases/topoisomerase IV, with low resistance.Formula:C22H24FN5O5SColor and Shape:SolidMolecular weight:489.52MIF2-IN-1
MIF2-IN-1, potent inhibitor of MIF2 (IC50: 1μM), halts non-small cell lung cancer growth via MAPK pathway.Formula:C26H19F3N2O2SColor and Shape:SolidMolecular weight:480.5EGFR-IN-44
EGFR-IN-44: potent EGFR kinase inhibitor, orally active, IC50 4.11 nM, 33.57% bioavailability, induces apoptosis, for lung cancer study.Formula:C27H29ClN6O2SColor and Shape:SolidMolecular weight:537.08HIV-1 inhibitor-41
HIV-1 inhibitor-41 (B23): Oral non-nucleoside reverse transcriptase blocker, EC50 of 50 nM (E138K), 20.8 nM (WT), low hERG/CYP impact, non-toxic.Formula:C16H15F2N3OSColor and Shape:SolidMolecular weight:335.37OXS007417
OXS007417 induces AML cell differentiation at 48 nM EC50 and shows potent in vivo antitumor effects.Formula:C20H14F3N3OColor and Shape:SolidMolecular weight:369.34Carbonic anhydrase inhibitor 10
CA inhibitor 10 targets MCF-7 cells, IC50: 11.9 μM; potent h CA IX inhibitor, Ki: 6.2 nM. Anti-cancer research.Formula:C14H17N5O3SColor and Shape:SolidMolecular weight:335.38UK 356618
CAS:<p>UK 356618 is a potent and selective inhibitor of matrix metalloprotease-3 (IC50: 5.9 nM).</p>Formula:C34H43N3O4Purity:98%Color and Shape:SolidMolecular weight:557.72BMS-751324
CAS:<p>BMS-751324: p38α MAPK inhibitor with carbamyl-methyl, esters, phosphate from HPA. Reduces rat arthritis swelling and TNFα.</p>Formula:C32H35N6O10PColor and Shape:SolidMolecular weight:694.63Trk-IN-7
<p>Trk-IN-7 inhibits TRKA/B/C (IC50: 0.25-10 nM) & EML4-ALK (<15 nM), also targets various ALK mutations (IC50: 5-50 nM).</p>Formula:C18H17FN6O2Color and Shape:SolidMolecular weight:368.36α5β1 integrin agonist-1
CAS:α5β1 integrin agonist-1 is an α5β1 integrin agonist that selectively delivers 5-FU to tumour cells and induces tumour cell death.Formula:C24H26FN5O9Color and Shape:SolidMolecular weight:547.49OP-2507
CAS:OP-2507, a prostacyclin agonist, is used potentially for the treatment of hepatic insufficiency and hypertension.Formula:C25H41NO4Purity:98%Color and Shape:SolidMolecular weight:419.6Tubulin polymerization-IN-8
CAS:Compound IIc inhibits tubulin polymerization, arrests cell cycle at G2/M in HCT116 cells, IC50 12.7 μM, potential for cancer research.Formula:C21H24N4O4SColor and Shape:SolidMolecular weight:428.5AKN-028 acetate
AKN-028 acetate: an oral TK inhibitor for AML research, targets FLT3 with IC50 of 6 nM, inhibits autophosphorylation, and induces apoptosis.Formula:C19H18N6O2Color and Shape:SolidMolecular weight:362.39LSD1/ER-IN-1
LSD1/ER-IN-1 inhibits ER & LSD1 (IC50: 1.55 μM), and fights MCF-7 breast cancer (IC50: 8.79 μM).Formula:C23H18FNO6SColor and Shape:SolidMolecular weight:455.46M3258
CAS:LMP7-IN-1 may used in the research of inflammatory and autoimmune diseases, neurodegenerative diseases, proliferative diseases and cancer, is an inhibitor ofFormula:C17H20BNO5Purity:98%Color and Shape:SolidMolecular weight:329.16Everafenib
Everafenib: potent BRAF inhibitor, crosses blood-brain barrier, hinders MAPK, effective on V600EBRAF cells, outperforms other drugs in trials.Formula:C20H23ClFN5O2S2Color and Shape:SolidMolecular weight:484.01RK-582
CAS:RK-582: oral spiroindolinone tankyrase inhibitor, halts colon cancer growth in COLO-320DM mouse model.Formula:C27H35FN6O3Color and Shape:SolidMolecular weight:510.6BET-IN-1
BET-IN-1 is a potent inhibitor of BET, exhibiting good brain permeability and a reasonable metabolic stability.Formula:C23H24ClFN4O3SColor and Shape:SolidMolecular weight:490.98

